One-sample and two-sample analysis of heterogeneous person-time data in clinical trials.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 194, doi. 10.1002/pst.526
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2012 AND VI 11 AND IP 3
Results: 13
1
2
Common statistical methods for clinical research with SAS examples, 3rd edition.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 271, doi. 10.1002/pst.1501
- By:
- Publication type:
- Article
3
An introduction to generalized linear models-third edition.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 272, doi. 10.1002/pst.1502
- Publication type:
- Article
4
Blinded assessment of treatment effects for survival endpoint in an ongoing trial.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 204, doi. 10.1002/pst.535
- By:
- Publication type:
- Article
5
Adaptive blinded sample size adjustment for comparing two normal means-a mostly Bayesian approach.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 230, doi. 10.1002/pst.538
- By:
- Publication type:
- Article
6
Escalation strategies for combination therapy Phase I trials.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 258, doi. 10.1002/pst.1497
- By:
- Publication type:
- Article
7
Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 222, doi. 10.1002/pst.537
- By:
- Publication type:
- Article
8
Expected loss functions as additional measures to assess performance of multiple testing procedures for combination drug dose finding.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 250, doi. 10.1002/pst.542
- By:
- Publication type:
- Article
9
PSI's Pharmaceutical Statistics Journal Club.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 193, doi. 10.1002/pst.1513
- By:
- Publication type:
- Article
10
Rank-based estimate of four-parameter logistic model.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 214, doi. 10.1002/pst.536
- By:
- Publication type:
- Article
11
Comments on 'Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design' by Satoshi Morita and Junichi Sakamoto. Pharmaceutical Statistics.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 267, doi. 10.1002/pst.539
- By:
- Publication type:
- Article
12
Adaptive designs for single-arm phase II trials in oncology.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 241, doi. 10.1002/pst.541
- By:
- Publication type:
- Article
13
Literature Review October 2011 - March 2012.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 3, p. 269, doi. 10.1002/pst.1511
- By:
- Publication type:
- Article